17th Annual Congress of the European Society for Photodynamic Therapy

OncoThAI will attend the 17th Congress of the European Society for Photodynamic Therapy in Nice, France On March 16th and 17th 2018.

Industrial development of PhoS-Istos project

Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.

Special issue of the Lasers in Surgery and Medicine journal

This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.

English Channel swimming and pleural cancer

On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.

Enrollment phase of INDYGO is now successfully achieved

After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial

Analysis phase of PHOS-ISTOS clinical trial is now achieved

This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.

Interview of Pr. Mordon during the EADV congress

Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.

Photodynamic Therapy and Photodiagnosis Update 2020

Save the date: Update PDT-PDD 2020 will be held in Nancy, France!

Photodynamic Therapy and Photodiagnosis Update – September 2018

OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)

Rare diseases foundation and OncoThAI

OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord

Photodynamic Therapy and OncoThAI illustrated in Nature journal

The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal

OncoThAI will attend the 2018 EANS congress in Brussels

The INDYGO clinical trial presented during the annual EANS meeting

Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Myrian® Studio Challenge 2018

Third place for OncoThAI

Back